Section 5-510(k) Summary. This document is provided in the following pages. DEC 2 92010



Similar documents
October 28, Cavex Holland Bv Mr. Richard Woortman Manager Technical Services Fustweg 5 Haarlem, 2031CJ The NETHERLANDS

(k)Suminary k

GE Healthcare MAR

510(k) Summary. Dentsply Implants. April 30, 2013

Lewis Ward L.W. Ward and Associates, Inc Kirkwood Court Boulder, CO

510(K) SUMMARY [as required by section (c)] FLIGHT 60 Ventilator 510(k) Number K IaO?2Z, JUL

Simpler Implant Solutions Inc Arbutus St. Vancouver, BC V6i 3Y9. haroldbergmanl~ogmail.com Telephone Fax K080115

February 5, Dear Kristin Pabst,

May 7, Tactile Systems Technology Inc Daniel Chase V.P. Engineering & Operations 1331 Tyler St NE Minneapolis, Minnesota 55413

EM GR.OUF DIPLOMAT. OT39?1 Company Name: (K)SUMMARY Oc. Submission Correspondent. Emergo Group, Inc. Company Address:

JUN 2 6 butt. EkoSonicTM Endovascular System with Rapid Pulse Modulation

Q(K SVJM~jPagelIof 3

ItP. Section I. 510(k) Summary of Safety and Effectiveness. Applicant:

February 22, Life Spine, Incorporated Mr. Randy Lewis General Manager 2401 West Hassell Road, Suite 1535 Hoffman Estates, Illinois 60169

August 12, Oertli Instrumente AG Ms. Karin Rohr Head of Quality Management & Regulatory Affairs Hafnerwisenstrasse 4 CH 9442 Berneck Switzerland

kok1 UQ 510(k)J Device {Applicant 510(k) Summary (per 21 CFR (c)) OCT Applicant

January 12, Dear Amy Yang:

0 EC V-,) 133 Lj9a

,11 DSA Cable, transducer and VS3, VS4 electrode, patient connector

July 24, Dear Ms. Rhodes:

March 20, Dear Mr. Chen:

510(k) SUMMARY MANI Needle and Suture Pack MANI, Inc.

Building 6, Suite 300 RyeBrook, NY C-ontact-N~ame: --- William H-. Schofield Director of TeleHealth Operations. Signal,_Radiofrequency

March 3, Dear Ms. Alice Gong,

2. Contact Person: Garo Mimaryan, MS., RAC 7 Technical Regulatory Affairs Specialist III 3. Phone Number: (914)

Dental Morelli Ltda.

November 20, Vascular Flow Technologies Ltd. Edwin Lindsay VP of QA/RA Prospect Business Centre, Gemini Cresent Dundee DD2 1TY United Kingdom

May 5, Dear Mr. Courtney:

510(k) Summary. Atlanti STM Abutment and AtlantisTM Crown Abutment in Zirconia for Dentsply Ankylos Implant

Phoenix Thera-Lase Systems, LLC Ms. Diane Rutherford Ken Block Consulting 1201 Richardson Drive, Suite 280 Richardson, Texas 75080

510(K) SUMMARY. 510(k) Number KOS'00-r

Ultimate Concepts Inc.

Ad-tech Medical Instrument Corporation. Principal Consultant Quality & Regulatory Associates, LLC. 800 Levanger Lane. Stoughton, Wisconsin 53589

University of Texas Medical School at Houston. April 14, 2015

SECTION 5 BARDEX TEMPERATURE-SENSING FOLEY CATHETER 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS INFORMATION

April 7, Acclarent, Inc. Mr. James Patrick Garvey II Sr. Manager, Regulatory Affairs 1525-B O'Brien Drive Menlo Park, CA 94025

AW Server 510 (k) Summary of Safety and Effectiveness

L~l t l V~! MAY ?

Brainreader ApS February 4, 2015 C/O Mette Munch QA Consultant Skagenvej 21 Egaa, 8250 DENMARK

August 21, TCM Associates Ltd Mr. Iain Alligan Technical Director 3 Hillgrove Business Park Nazeing Road Essex EN9 2HB United Kingdom

DICOM Grid, Inc. January 25, Senior Consultant Biologics Consulting Group, Inc. 400 N. Washington Street, Suite 100 ALEXANDRIA VA 22314

BMR ~131o-lvleccai Kesearcn Ltd.

DEC The three components of the Axxent Electronic Brachytherapy System include the Controller, Balloon Applicators-BR and X-ray Source.

sbchoi~kku.edu jeremy~sooil.com DANA Diabecare IlS Insulin Infusion pump Infusion pump Class II

June 9, Stryker Corporation Garry T. Hayeck, Ph.D. Senior Regulatory Affairs Specialist 2 Pearl Court Allendale, New Jersey 07401

MViAKIO. V.A hn2 ATTACHMENT I 610(K) SUMMARY. Submitter:

November 17, Nanova Biomaterials, Inc. Mr. Andrew Ritts Senior Research Scientist 3806 Mojave Ct Columbia, Missouri, 65202

510(k) SUMMARY APR Date: 15 th December 2008

MAY SECTION VIII. 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS

D I Z1. 510(k) Summary. Section 5. Siemens Medical Solutions USA, Inc. Oncology Care Systems. Date Prepared: September 09,

510(k) Summary GlobalMedia Group, LIC. MAY CONiM

AgaMatrucx. NV2 21 Salem, NH oz (k) Sumnmary

September 25, Dear Ms. McCoy:

510(k) Summary of Safety and Effectiveness JUN Hip prosthesis

October 29, Dear Ms. Hartnett:

SUMMARY OF SAFETY AND EFFECTIVENESS for Powered Muscle Stimulator

KIZ 2,33-3 p8 ~ 510(k) Summary. As required by 21 CFR (c) 510(k) Premarket Notification Submission AFrame Digital MobileCare Monitor.

May 22, Rachel s Remedies, LLC Mrs. Rachel E. Jackson 2316 Delaware Ave. #174 Buffalo, New York 14216

Koqo8 go. ER35 ERO-SCAN Pro Hearing Test System. 61 Martin Lane Elk Grove Village, IL Manager of Instrumentation Products

51O(K) SUMMARY: Therapy family of devices.

MAY Attachment (k) Summary 21 CER

Manufacturing Technology, Inc.

510(k) Summary (c)

Datrix, Inc NOV Appendix G. 510(k) Summary of Safety and Effectiveness for Datrix, Inc CardioServer ECG Management System

March 31, Etiometry, Inc. Richard Galgon Independent Consulting Associate Quintiles 5846 Cobblestone Lane Waunakee, Wisconsin 53597

RAMSOFT BUG ,-. I"-, --I 2 N Tel: (416) Fax: (416) sales@ramsoftbiz (k) Summary

OCT 18 20U5Ibko. a. Submitter Name: Cosmetic Dental Materials Inc. (CDM Inc.) b. Submitter Address: 812 Water St. NE Albany OR 97321

July 21, Dentca, Inc. c/o Mr. Claude Berthoin Denterprise International, Inc. 110 East Granada Blvd, Suite 207 Ormond Beach, Florida 32176

MAR (k) SUMMARY OF SAFETY AND EFFECTIVENESS (21CFR ) 1. DATE PREPARED: 4/21/2008

Dear Ms. Lucas: This letter corrects our substantially equivalent letter of February 18, 2016.

Fresenius Medical Care

Ni Hau Industrial Co., Ltd. Ms. Lyn Chiu Sales Manager No. 15, Alley 125, Lane 318, Section 2, An Ho Road Tainan City, Taiwan 70967

510(K) Summary K102148

May 20, Ivoclar Vivadent Ag Ms. Donna Hartnett Director Regulatory Affairs Ivoclar Vivadent, Inc. 175 Pineview Drive Amherst, New York 14228

510(k) Summary. (508) X222 Disposable Insulin Delivery Device

ATLANTIS Anterior Cervical Plate System ATLANTIS Translational Plate. 510(k) Summary. February 2007

foq8 510(k) Summary fo r PAIRIETEX ~ COMPOSITE Mesh

510(k) SUMMARY JUL Otoharmonics 0 Levo 9 System

smith sm e 0L Zw.. bringing technology to life

DEC V,(9/azO (c 0 j

Section (K) Summary. Kimberly-Clark Corporation Winchester Road Neenah, WI 54956

510(k) SUMMARY. OPTION-vyM Urinary Catheter

March 23, Vision Quest Industries, Inc. Mr. Mohammed Ouerghi Director of QA/RA 1390 Decision Street, Suite A Vista, CA 92081

JN (k) Summary Device Identification: Device Description:

ELASTO-GEL MANIJKAH"O"NEY JUUjj 2. fudbthsarltvl of the wound fluid, while re~leas'ing

Summary of Safety and Effectiveness

Food and Drug Administration 5 10(k) Notijfication - Partial & Total Ossicular Replacement Prostheses AUG I June 30, 2006

Histoacryl Flexible Topical Skin Adhesive April15, 2013

I C 5 5l v ri 510(K) SUMMARY. Prowess Panther

r5 73~ 9/ / 510(K) Summary (K) SUMMARY

510(k) Summary Special Premarket Notification 510(k) Section 6

Transcription:

Section 5-510(k) Summary This document is provided in the following pages. DEC 2 92010

DC221 510(k) SUMMARY This summary of 5 10(k) safety and effectiveness information is being submitted in accordance with the requirements of 21 CFR 807.92. Sponsor Information: Atom Medical Corporation 3-18-15, Hongo, Bunkyo-ku 113-0033 Tokyo Japan Date Summary Prepared: July 30, 2010 Contact Person: Mr. Tsuyoshi Sugino Atom Medical Corporation Regulatory Affairs Department Manager TEL ±81-3-3815-3632 FAX +8 1-3-3812-3 199 E-mail t-sugino(.aatomed.co.in Device Name: Trade Name(s): Jncu i (Atom Infant Incubator Model 101) Classification Name: Neonatal Incubator Classification Regulation: 880.5400 Panel: General Hospital Product Code: FMZ Predicate Device Information: Device Name: V-2200 Infant Incubator 510(k) Reference: K061856 Manufacturer: Atom Medical Corporation Device Name: Caleo 510(k) Reference: K(003067 Manufacturer: DRAGER MEDIZINTECI-NIK GMBH- Device Description: Incu i (Atom Infant Incubator Model 10 1) consists of a hood, a main body, a control panel and a stand with casters. A hood consists of a canopy and access doors (Snap-open access port). An Oxygen sensor, a humidity sensor and a temperature sensor which monitor the air conditions inside the hood, are connected to the sensor module. A main body consists of a mattress, a mattress platform, a conditioning chamber, a humidity chamber. A control panel and skin temperature sensors are connected to the main body. This product has 2 types of function modes; one is skin temperature control mode and another is air temperature control mode. The skin temperature control mode is called "servo control mode" also, and the air temperature control mode is called "manual control mode" also. In "servo control mode", skin temperature can be set from 34 0 C to 38 0 C (including override).

In "manual control mode", air temperature inside the hood can be set from 23 0 C to 39 0 C (including override). In "servo control mode", baby's skin temperature is monitored by temperature sensor attached on baby's body, and baby's skin temperature is controlled according to difference between monitored baby's skin temperature and set skin temperature. In "manual control mode", air temperature inside the hood is monitored by temperature sensor of sensor module, and air temperature inside the hood is controlled according to difference between monitored air temperature inside the hood and set air temperature. The mattress platform can be tilted. X-ray cassette tray is installed under the mattress platform. The device has 6 kinds of accessories; "Skin temperature probe (sensor)", "Oxygen sensor", "Piping hose for oxygen", "Electrostatics air filter", "Access port cover" and "Oxygen calibration tool", and these 6 accessories are available separately as replacements. "SpO2 Module", "Oxygen Controller", "Weight Monitor" and "Humidifier Chamber" are components of this device, and it is optional whether they are initial attached initially or not. If they are not attached initially, they can be attached later, and then SpO2/pulse monitoring, oxygen density controlling, weight monitoring and humidifying function can be available. The 4 kinds of components can be supplied individually. The stand can be gone up and down. Intended Use: The Incu i is an incubator for newborns and premature neonates. It is mainly intended for temperature control in neonatal hypothermia, observation and examination in newborn nurseries, prevention of body temperature drop shortly after delivery, and pre-operative and post-operative intensive care in neonatal surgery. This incubator is provided with a function to control the infant's skin temperature. Optional functions include nulse oximetrv. and oxygen density controlling. Comparison to Predicate Device: There are not main differences between lncu i and Atom V-2200. The technological characteristics of the incu i as compared to the predicate products. the Atom V- 2200 and Caleo. are equivalent in the following areas and do not compromise the safety or efficacy of the device. -intended use - Feature - Appearance - Temperature Modes -Components and those function Testing and Conclusions: Incu i is electrical medical device. Therefore, tests based on 1EC60601-I, IEC60601-1-2 and I EC6060 1-2-1 9 standards were carried out for Incu i, and it was verified that lncu i is met to requirements of 1EC6060 1-1, IEC60601I- 1-2 and 1EC60601-2-19. Biocompatibilitv was evaluated based on 1S010993-1. Infants-contacting parts of the lncu i are not unprecedented and are generally used for various tvne of medical devices. And also. the

materials are identical to those used for the 510(k)-cleared predicate device. Thus the biological safety can be evaluated to have been assured. Validation has been conducted on the device software.

DEPARTMENT OF HEALTH & HUMAN SERVICES 4 Food Public H-ealth Ser vice arid Dinug Administration 10903 New, Hampshire Avenue Document Control Roomn -W066-G609 Silver Spr ing, Nil 20993-0002 Mr. Tsuyoshi Sugino Regulatory Affairs Department Manager Atom Medical Corporation 3-18-15, Hongo, Bunkyo-ku 113-0033 TokyoPE JAPAN 29 0T Re: K102279 Trade/Device Name: Incu i (Atom Infant Incubator 101) Regulation Number: 21 CER 880.5400 Regulation Name: Neonatal Incubator Regulatory Class: 11 Product Code: FMZ Dated: December 20, 2010 Received: December 21, 2010 Dear Mr. Sugino: We have reviewed your Section 5 10(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual' registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDR- does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthfiul and not misleading. If your device is classified (see above) into either class 11 (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Page 2 - Mr. Sugino Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 53 1-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to littp://www.fda.g~ov/aboutfda/ceitersoffices'cdrh/cdrh~offices/uci 1 n 15809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (2ICFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://\www".fda.g2ov/medicaldevices/safety/reportaprobleni-/defaulthtm for the CDRI-'s Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http)://wvww.fda.g~ov/medicaldevices/resourcesforyou/industry/defatilthtni. Sincerely yours Anthony Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure

Indications for Use DEC 2 9 2010 510(k) Number (if known): ( J~ Device Name: Incu i (Atom Infant Incubator 101) Indications for Use: The Incu i is an incubator for newborns and premature neonates. It is mainly intended for temperature control in neonatal hypothermia, observation and examination in newborn nurseries, prevention of body temperature drop shortly after delivery, and pre-operative and post-operative intensive care in neonatal surgery. This incubator is provided with a function to control the infant's skin temperature. Optional fuinctions include pulse oximetry, and oxygen density controlling. Prescription Use _XX ADO Over-The-Counter Use (Part 21 CER 801 Subpart D) AN/R (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRI-, Office of Device Evaluation (ODE) I(Division Sip-Oil Division of Anesthesiolog, Inrection conto asntal Gemnal Hospital Device* 510(k) NmbKCL 227Z